NCT06178042

Brief Summary

One of the most undesired side effects of fixed orthodontic treatment is white spot lesions (WSLs), that appear on the buccal surface of teeth and cause aesthetic problems. The aim of this prospective study was to quantitively evaluate the remineralization effect of casein phosphopeptide-amorphous calcium fluorophosphate (CPP-ACFP) containing (MI Paste Plus®) and hydroxyapatite, xylitol and fluoride containing (Remin Pro®) agents in remineralizing post orthodontics white spots using Quantitive Light-Induced Fluorescence Method (QLF) and ICDAS II criteria, compared to a control group in whom just a routine home care was instructed. Thirty-nine individuals who had recently completed orthodontic treatment, had at least one WSL on upper anterior teeth and aged between 12-25 years were included. The participants were randomly assigned into three groups of 13 each; (1) MI Paste Plus + routine home care; (2) Remin Pro + routine home care; and (3) routine home care (control). The treatment/ observation period was 12 weeks after bracket debonding. Fluorescence loss (∆F, %), lesion area (LA, mm2), lesion volume (∆Q, % × mm2), maximum fluorescence loss (∆Fmax), ICDAS II criteria of WSLs were measured at beginning (T0) and 4 (T1), 8 (T2), and 12 (T3) weeks later. Statistical significance was set at p\<0.05.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2022

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

September 18, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 20, 2023

Completed
Last Updated

December 20, 2023

Status Verified

December 1, 2023

Enrollment Period

2 years

First QC Date

September 18, 2023

Last Update Submit

December 11, 2023

Conditions

Keywords

White Spot LesionRemineralizationQLFICDAS II

Outcome Measures

Primary Outcomes (4)

  • Mineral Content Assessment (ΔF / Depth of lesion)

    The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.

    The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.

  • Mineral Content Assessment (LA / Lesion area)

    The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.

    The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.

  • Mineral Content Assessment (∆Q / Lesion volume)

    The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.

    The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.

  • Mineral Content Assessment (∆Fmax / Maximum fluorescence loss)

    The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.

    The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.

Secondary Outcomes (1)

  • Visual Caries Regression Assessment

    The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.

Study Arms (3)

MI Paste Plus

EXPERIMENTAL

Patients were instructed to use MI Paste Plus (GC Europe, Leuven, Belgium) according to manufacturers instructions.

Combination Product: MI Paste Plus

Remin Pro

EXPERIMENTAL

Patients were instructed to use (Remin Pro, VOCO GmbH, Cuxhaven, Germany) a pea-sized amount of the cream.

Combination Product: Remin Pro

Control

ACTIVE COMPARATOR

Patients used a 1450 ppm fluoridated tooth paste (Colgate Sensitive Pro-Relief, Colgate-Palmolive, Swidnica, Poland) for conventional tooth brushing.

Combination Product: Control

Interventions

MI Paste PlusCOMBINATION_PRODUCT

Briefly, a pea-sized amount of the cream was used once a day and was allowed to remain on the teeth for three minutes after conventional tooth brushing. Patient was advised to not to spit out the cream for 30 seconds to activate the product with saliva. Patient was advised to spit out the remaining amount to avoid swallowing excessive fluoride and to wait for 30 minutes after the treatment before rinsing or eating or drinking.

MI Paste Plus
Remin ProCOMBINATION_PRODUCT

The cream must remain on the teeth for at least three minutes once daily after conventional tooth brushing. Patient was advised to spit out the remaining amount to avoid swallowing excessive fluoride and to wait for 30 minutes after the treatment before rinsing or eating or drinking.

Remin Pro
ControlCOMBINATION_PRODUCT

Patients instructed to follow a routine home care.

Control

Eligibility Criteria

Age12 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • to 25 years of age,
  • at least 12 months of orthodontic treatment with braces,
  • at least one upper anterior tooth with WSL.

You may not qualify if:

  • smoking,
  • enamel hypoplasia or fluorosis,
  • active periodontal disease,
  • dentin caries,
  • allergy to casein,
  • previous bleaching.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sevgi Göl Peynirci

Konak, İzmir, 35220, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blinding was not feasible during the intervention, but the data evaluation and outcome assessment were blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Thirty-nine patients were randomized in a 1:1:1 ratio to either MI Paste Plus or Remin Pro or control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 18, 2023

First Posted

December 20, 2023

Study Start

February 1, 2020

Primary Completion

February 1, 2022

Study Completion

May 25, 2022

Last Updated

December 20, 2023

Record last verified: 2023-12

Locations